Randomized controlled trial of magnesium sulfate in women at risk of preterm delivery—neonatal cardiovascular effects

Objective: Use of antenatal magnesium sulfate (MgSO 4 ) may reduce cerebral palsy in infants born very preterm. Low systemic blood flow in the first day in very preterm infants has been associated with cerebral injury and adverse motor outcome. The aim was to determine the effect of MgSO 4 on system...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of perinatology 2012-09, Vol.32 (9), p.665-670
Hauptverfasser:	Paradisis, M, Osborn, D A, Evans, N, Kluckow, M
Format:	Artikel
Sprache:	eng
Schlagworte:	631/443/1338/2729 631/92/609 692/699/375 692/700/1720 Blood flow Cerebral palsy Cerebral Palsy - prevention & control Clinical trials Complications and side effects Dosage and administration Echocardiography Exposure Female Health aspects Heart rate Hemodynamics - drug effects Humans Hypotension Hypoxia Infant, Newborn Infant, Premature - physiology Infants Infants (Premature) Ischemia Magnesium sulfate Magnesium Sulfate - pharmacology Medicine Medicine & Public Health Neonates Neuroprotective Agents - pharmacology Newborn babies original-article Paralysis Pediatric Surgery Pediatrics Pharmacists Physiological aspects Placebos Pregnancy Premature babies Premature birth Premature Birth - prevention & control Prevention Pulmonary hypertension Regional Blood Flow Risk factors Sulfates Systematic review Testing Tocolytic Agents - pharmacology Vena Cava, Superior - physiology Ventricle Ventricular Function, Right - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!